NCT07594899 AI-Driven Treatment Strategy vs Pola-R-CHP in Untreated LBCL Status NOT_YET_RECRUITING Phase PHASE2
NCT07548606 A Drug-Drug Interaction Study of Itraconazole and Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-017) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT07535762 Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07535710 Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07493148 Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL Status RECRUITING Phase PHASE2
NCT07451665 Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis Status NOT_YET_RECRUITING Phase PHASE4
NCT07444710 Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07431060 Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis Status RECRUITING Phase NA
NCT07426484 Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy Status NOT_YET_RECRUITING Phase PHASE4
NCT07418177 Study in Human iPSCs-derived RPE Cells Transplantation for Late-Stage AMD Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07412470 A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation Status RECRUITING Phase PHASE2/PHASE3
NCT07339267 A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer Status RECRUITING Phase PHASE1
NCT07278856 Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas Status NOT_YET_RECRUITING Phase PHASE1
NCT07258680 BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas Status ENROLLING_BY_INVITATION Phase PHASE3
NCT07237269 Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer Status RECRUITING Phase PHASE2
NCT07225946 A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer Status RECRUITING Phase PHASE3
NCT07224100 Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma Status RECRUITING Phase PHASE2
NCT07220187 Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial Status NOT_YET_RECRUITING Phase PHASE3
NCT07124936 A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma Status RECRUITING Phase PHASE1/PHASE2